Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice.

Ahuja, Dhruv; Singh, Siddharth

Ahuja, Dhruv; Singh, Siddharth.

Affiliation

Ahuja D; Department of Medicine, Janakpuri Super Specialty Hospital, New Delhi, New Delhi, India.
Singh S; Division of Gastroenterology.

Curr Opin Gastroenterol ; 38(4): 337-346, 2022 07 01.

Article in En | MEDLINE | ID: mdl-35762693

Subject(s)

Biosimilar Pharmaceuticals; Colitis, Ulcerative; Inflammatory Bowel Diseases; Adalimumab/therapeutic use; Biosimilar Pharmaceuticals/therapeutic use; Chronic Disease; Clinical Trials, Phase III as Topic; Colitis, Ulcerative/drug therapy; Humans; Inflammatory Bowel Diseases/drug therapy; Infliximab/therapeutic use; Randomized Controlled Trials as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / Biosimilar Pharmaceuticals Type of study: Clinical_trials / Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: Curr Opin Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2022 Type: Article Affiliation country: India

Fulltext

XML

PubMed Links

Search on Google